Valuation: ZIM Laboratories Limited

Market Cap 7.41B 77.35M 67.88M 64.11M 58.42M 109M 110M 767M 297M 3.79B 290M 284M 12.17B P/E 2025
32.1x
P/E 2026 50.3x
Enterprise Value 8.28B 86.36M 75.78M 71.57M 65.22M 122M 123M 856M 332M 4.23B 324M 317M 13.59B EV / Sales 2025
1.34x
EV / Sales 2026 1.09x
Free-Float
28.77%
Yield 2025 *
-
Yield 2026 -
1 day-1.56%
1 week+2.33%
Current month+11.97%
1 month+10.27%
3 months+11.79%
6 months+117.62%
Current year+92.59%
1 week 130.35
Extreme 130.35
143.2
1 month 112
Extreme 112
144.85
Current year 59.72
Extreme 59.72
144.85
1 year 59.72
Extreme 59.72
144.85
3 years 59.72
Extreme 59.72
144.85
5 years 36.37
Extreme 36.366666
151.75
10 years 14
Extreme 14
151.75
Manager TitleAgeSince
Chief Executive Officer - 01/01/2002
Director of Finance/CFO - 01/04/2019
Director of Finance/CFO - 01/01/1991
Director TitleAgeSince
Chairman - 01/01/1990
Director/Board Member - 01/01/1991
Director/Board Member - 01/01/2013
Change 5-day change 1-year change 3-year change Capi.($)
-1.56%+2.33%+88.73%+11.34% 77.35M
+0.12%+0.81%+16.73%+64.52% 46.37B
+1.09%+0.36%+43.72%+108.13% 37.26B
+2.00%+3.78%+23.48%+101.30% 12.53B
+0.05%+0.37%-6.65%+20.29% 11.8B
0.00%0.00%+17.65%+141.86% 8.97B
-1.34%-2.73%+27.74%+37.90% 7.09B
-2.07%-2.75%+20.71%+212.23% 7.01B
+1.43%+2.22%+41.73%-13.30% 7.29B
-2.45%-0.59%-50.18%+3.88% 4.99B
Average -0.27%+0.38%+22.37%+68.82% 14.34B
Weighted average by Cap. +0.32%+0.54%+22.19%+80.07%

Financials

2025 2026
Net sales 3.79B 39.56M 34.71M 32.78M 29.88M 55.93M 56.33M 392M 152M 1.94B 149M 145M 6.23B 3.74B 39.06M 34.28M 32.37M 29.5M 55.23M 55.62M 387M 150M 1.91B 147M 143M 6.15B
Net income 122M 1.27M 1.11M 1.05M 959K 1.79M 1.81M 12.59M 4.88M 62.15M 4.77M 4.66M 200M 58.38M 609K 535K 505K 460K 861K 867K 6.04M 2.34M 29.83M 2.29M 2.24M 95.86M
Net Debt 1.16B 12.08M 10.6M 10.01M 9.12M 17.08M 17.2M 120M 46.39M 591M 45.35M 44.37M 1.9B 863M 9M 7.9M 7.46M 6.8M 12.73M 12.82M 89.31M 34.59M 441M 33.81M 33.08M 1.42B
Logo ZIM Laboratories Limited
ZIM Laboratories Limited is a pharmaceutical company. The Company develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. It is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.
Employees
632
Date Price Change Volume
25/09/26 ₹138.45 -1.56% 10,677
24/09/26 ₹140.65 +4.53% 12,704
23/09/26 ₹134.55 +0.64% 7,657
22/09/26 ₹133.70 -0.19% 4,678
21/09/26 ₹133.95 -1.00% 5,345
  1. Stock Market
  2. Stocks
  3. 541400 Stock